(GLP-1 receptor agonist + GIP receptor agonist + Glucagon receptor agonist)

Retatrutide is a research peptide being studied for its possible effects on appetite, fat metabolism, blood sugar, and body weight. Researchers are especially interested in it because it works through three different signaling pathways at the same time.

GLP-1 signal – researchers study this pathway for how it may increase fullness, reduce cravings, and slow digestion.
GIP signal – researchers study how this pathway may affect the way the body handles blood sugar and stores or uses fat.
Glucagon signal – researchers study how this pathway may affect energy use and fat metabolism.

Together, these three signals are being studied for their combined effects on appetite, weight management, blood
sugar, and fat metabolism.

Benefits:
Appetite control
Reduced cravings
Weight and fat loss
Blood sugar control
Body composition
Cholesterol and triglycerides

Retatrutide may be of interest in research focused on appetite, weight management, fat metabolism, blood sugar, and body composition. It may be especially relevant when several of these areas are part of the same research focus.

Research Use Only. Products are intended for laboratory and research purposes only and are not intended for human consumption or clinical use.